Wei, Jiacong
Meng, Pei
Terpstra, Miente Martijn
van Rijk, Anke
Tamminga, Menno
Scherpen, Frank
ter Elst, Arja
Alimohamed, Mohamed Z.
Johansson, Lennart F.
Stigt, Jos
Gijtenbeek, Rolof P. G.
van Putten, John
Hiltermann, T. Jeroen N.
Groen, Harry J. M.
Kok, Klaas
van der Wekken, Anthonie J.
van den Berg, Anke
Article History
Accepted: 3 February 2021
First Online: 19 February 2021
Declarations
:
: This work was funded by a KWF grant (RUG2015-8044) and the University Medical Centre Groningen.
: Harry J.M. Groen reports grants from Boehringer-Ingelheim, Takeda, BMS, Novartis, and Merck outside the submitted work. Anthonie J. van der Wekken has received research grants from AstraZeneca, Pfizer, Boehringer-Ingelheim, Roche, and Takeda. Jeroen Hiltermann reports grants from AstraZeneca, Pfizer, Boehringer-Ingelheim, Roche, BMS, and MSD, outside the submitted work. Jiacong Wei, Pei Meng, Miente Martijn Terpstra, Anke van Rijk, Menno Tamminga, Frank Scherpen, Arja ter Elst, Mohamed Z. Alimohamed, Lennart F. Johansson, Jos Stigt, Rolof P.G. Gijtenbeek, John van Putten, Klaas Kok, and Anke van den Berg have no conflicts of interest that are directly relevant to the content of this article.
: The study protocol is consistent with the Research Code of the University Medical Centre Groningen (ExternalRef removed) and national ethical and professional guidelines (“Code of conduct; Dutch Federation of Biomedical Scientific Societies”, htttp://ExternalRef removed).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed to the study conception and design, material preparation, data collection, and analysis. The first draft of the manuscript was written by Jiacong Wei and Pei Meng. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.